Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-069162
Filing Date
2024-03-15
Accepted
2024-03-15 16:16:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 8038
2 GRAPHIC g779091g76y75.jpg GRAPHIC 18553
3 GRAPHIC g779091snap1.jpg GRAPHIC 9030
  Complete submission text file 0001193125-24-069162.txt   47440
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

EIN.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)